All subcategories » published RCT
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.
primary studies published RCT
Details- 2025
- Durieu I
The effect of a 12-week tele-exercise using immersive virtual reality on functional capacity in adolescents with cystic fibrosis: A randomized controlled, single (assessor) - blind study.
primary studies published RCT
Details- 2025
- Ozyemisci Taskiran O
Efficacy of Adding Oral N acetyl Cysteine Supplement to the Cystic Fibrosis Treatment Regimen: A Randomized Quasi-Experimental Trial.
primary studies published RCT
Details- 2025
- Keshavarz S
Effectiveness of nutritional intervention package versus conventional nutritional counseling in pediatric cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2025
- Sharma R
The Impact of Mandala Coloring on Anxiety of Children with Cystic Fibrosis: A Randomized Trial.
primary studies published RCT
Details- 2025
- Omidi A
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension Study.
primary studies published RCT
Details- 2025
- Daines CL
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
primary studies published RCT
Details- 2025
- West NE
MetaNeb Versus Usual Care During Exacerbations of Cystic Fibrosis: An RCT.
primary studies published RCT
Details- 2025
- Chapman N
Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia.
primary studies published RCT
Details- 2025
- Schoop AC
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trial.
primary studies published RCT
Details- 2025
- Plant BJ